| 1 |
Zamor PJ , Lane AM . Interpretation of HBV serologies[J]. Clin Liver Dis, 2021, 25 (4): 689- 709.
doi: 10.1016/j.cld.2021.06.012
|
| 2 |
Pollicino T , Caminiti G . HBV-integration studies in the clinic: Role in the natural history of infection[J]. Viruses, 2021, 13 (3): 368.
doi: 10.3390/v13030368
|
| 3 |
Bello KE , Mat Jusoh TNA , Irekeola AA , et al. A recent prevalence of hepatitis B virus (HBV) genotypes and subtypes in Asia: A systematic review and meta-analysis[J]. Healthcare, 2023, 11 (7): 1011- 1018.
doi: 10.3390/healthcare11071011
|
| 4 |
Gu Y , Li X , Gu L , et al. An immuno-clinic score model for evaluating T cell immunity and predicting early antiviral therapy effectiveness in chronic hepatitis B[J]. Aging, 2020, 12 (24): 26063- 26079.
doi: 10.18632/aging.202274
|
| 5 |
Li K , Liu H , Guo T . Th17/Treg imbalance is an indicator of liver cirrhosis process and a risk factor for HCC occurrence in HBV patients[J]. Clin Res Hepatol Gastroenterol, 2017, 41 (4): 399- 407.
doi: 10.1016/j.clinre.2016.12.004
|
| 6 |
Jose-Abrego A , Roman S , Laguna-Meraz S , et al. Host and HBV interactions and their potential impact on clinical outcomes[J]. Pathogens, 2023, 12 (9): 1146- 1152.
doi: 10.3390/pathogens12091146
|
| 7 |
Nicolini LA , Orsi A , Tatarelli P , et al. A global view to HBV chronic infection: Evolving strategies for diagnosis, treatment and prevention in immunocompetent individuals[J]. Int J Environ Res Public Health, 2019, 16 (18): 3307.
doi: 10.3390/ijerph16183307
|
| 8 |
Hogan S , Page A , Dixit S , et al. HBV prevalence in Sub-continental countries: A systematic review and meta-analysis[J]. PLoS One, 2023, 18 (12): e0295670.
|
| 9 |
Chen J , Li L , Yin Q , et al. A review of epidemiology and clinical relevance of hepatitis B virus genotypes and subgenotypes[J]. Clin Res Hepatol Gastroenterol, 2023, 47 (7): 102180.
doi: 10.1016/j.clinre.2023.102180
|
| 10 |
Wang L , Zeng X , Wang Z , et al. Recent advances in understanding T cell activation and exhaustion during HBV infection[J]. Virol Sin, 2023, 38 (6): 851- 859.
doi: 10.1016/j.virs.2023.10.007
|
| 11 |
Wan Z , Zhou Z , Liu Y , et al. Regulatory T cells and T helper 17 cells in viral infection[J]. Scand J Immunol, 2020, 91 (5): e12873.
doi: 10.1111/sji.12873
|
| 12 |
高鹏, 雒艳萍. 乙型肝炎病毒在不同丙氨酸氨基转移酶状态下对Th17、Treg细胞及其比率的影响[J]. 北京大学学报(医学版), 2022, 54 (2): 272- 277.
doi: 10.19723/j.issn.1671-167X.2022.02.012
|
| 13 |
Beňová K , Hancková M , Koći K , et al. T cells and their function in the immune response to viruses[J]. Acta Virol, 2020, 64 (2): 131- 143.
doi: 10.4149/av_2020_203
|
| 14 |
Cui D , Jiang D , Yan C , et al. Immune checkpoint molecules expressed on CD4+ T cell subsets in chronic asymptomatic hepatitis B virus carriers with hepatitis B e antigen-negative[J]. Front Microbiol, 2022, 13, 887408.
doi: 10.3389/fmicb.2022.887408
|
| 15 |
Xu J , Zhan Q , Fan Y , et al. Human genetic susceptibility to hepatitis B virus infection[J]. Infect Genet Evol, 2021, 87, 104663.
|
| 16 |
Revill PA , Tu T , Netter HJ , et al. The evolution and clinical impact of hepatitis B virus genome diversity[J]. Nat Rev Gastroenterol Hepatol, 2020, 17 (10): 618- 634.
|
| 17 |
Fernandes da Silva C , Keeshan A , Cooper C . Hepatitis B virus genotypes influence clinical outcomes: A review[J]. Can Liver J, 2023, 6 (3): 347- 352.
|
| 18 |
Likhitsup A , Lok AS . Understanding the natural history of hepatitis B virus infection and the new definitions of cure and the endpoints of clinical trials[J]. Clin Liver Dis, 2019, 23 (3): 401- 416.
|
)
